SCHEMBL104031

SCHEMBL104031

C[CH]CCCCCCCCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
THRB P10828 1/20 0.53
FAAH O00519 2/20 0.48
TRPV1 Q8NER1 1/20 0.48
DNM1 Q05193 3/20 0.47
EP300 Q09472 1/20 0.42
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
APEX1 P27695 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2190769 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL5394503 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL200765 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL199975 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL32612 1.00
SCHEMBL5403985 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL100327 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL20495965 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL20495962 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL100650 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115316384-B Antibacterial slow-release granule and preparation method thereof 深圳市光科全息技术有限公司 2024-05-14 CN claimed
US-20230220161-A1 POLYIMIDE PRECURSOR PREPARED BY USING POLYCYCLIC MONOMER INCLUDING TRIFLUOROMETHYL GROUP AND FLEXIBLE POLYIMIDE OBTAINED BY USING THE SAME KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-07-13 US claimed
CN-115316384-A Antibacterial sustained-release granules and preparation method thereof 深圳市光科全息技术有限公司 2022-11-11 CN claimed
CN-115304794-A Antibacterial sustained-release gel particles and preparation method thereof 深圳市光科全息技术有限公司 2022-11-08 CN claimed
EP-2181763-B1 Catalyst and process for alkoxylation SHELL INT RESEARCH (NL) 2012-06-20 EP claimed
US-20100261628-A1 ESTERS COMPRISING BRANCHED ALKYL GROUPS AS LUBRICANTS COGNIS IP MANAGEMENT GMBH (DE) 2010-10-14 US claimed
US-20100202992-A1 COMPOSITION CONTAINING A LIQUID FATTY PHASE GELLED WITH A SEMI-CRYSTALLINE COPOLYMER L'OREAL S.A. 2010-08-12 US claimed
EP-2181763-A1 Catalyst and process for alkoxylation Shell Internationale Research Maatschappij B.V. (NL) 2010-05-05 EP claimed
US-20090068133-A1 Composition containing a liquid fatty phase gelled with a semi-crystalline copolymer AIR PRODUCTS AND CHEMICALS, INC. 2009-03-12 US claimed
EP-1833458-A1 COMPOSITION CONTAINING A LIQUID FATTY PHASE GELLED WITH A SEMI-CRYSTALLINE COPOLYMER L'OREAL, S.A. (FR) 2007-09-19 EP claimed
WO-2005123011-A1 COMPOSITION CONTAINING A LIQUID FATTY PHASE GELLED WITH A SEMI-CRYSTALLINE COPOLYMER L'OREAL (FR) 2005-12-29 WO claimed
US-5208140-A Multilayer element with emulsion layer and quenching KONICA CORPORATION (JP) 1993-05-04 US claimed
EP-0477870-A1 Light-sensitive silver halide photographic material prevented in color contamination KONICA CORPORATION (JP) 1992-04-01 EP claimed
US-4465860-A Polyoxyethyleneated non-ionic surface-active agents with two lipophilic chains SOCIETE ANONYME DITE: L'OREAL (FR) 1984-08-14 US claimed
US-4399313-A COSMETICS FOR HAIR OR SKIN SOCIETE ANONYME DITE: L'OREAL (FR) 1983-08-16 US claimed
CN-118355051-A Polycarbonate resin composition 三菱化学株式会社 2024-07-16 CN disclosed
CN-111533929-B Fluorine-containing resin particle, composition, layered product, electrophotographic photoreceptor, process cartridge, and image forming apparatus 富士胶片商业创新有限公司 2024-07-12 CN disclosed
US-3987097-A INCREASING AFFINITY FOR ANIONIC DYES SANDOZ LTD. (CH) 1976-10-19 US disclosed
US-3948946-A Cyclic acetals and mercaptals SANDOZ LTD., (SANDOZ AG) (CH) 1976-04-06 US disclosed
US-3935015-A Silver halide color photographic materials containing 3-anilino-5-pyrazolane couplers FUJI PHOTO FILM CO., LTD. (JA) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100202992-A1 COMPOSITION CONTAINING A LIQUID FATTY PHASE GELLED WITH A SEMI-CRYSTALLINE COPOLYMER CUTA, FABP4, KRT18 TSHR 3636/4885THRB 1505/4885FAAH 837/4885
US-20090068133-A1 Composition containing a liquid fatty phase gelled with a semi-crystalline copolymer CUTA, FABP4, KRT18 TSHR 3919/4885THRB 2094/4885FAAH 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.